Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 4INDUSTRY 3FED 2

Study Type

Interventional 3

Sponsor

Conditions

Neoplasms 1905Breast Neoplasms 1427Carcinoma, Non-Small-Cell Lung 1179Prostatic Neoplasms 740Colorectal Neoplasms 686Neoplasm Metastasis 624Multiple Myeloma 548Melanoma 529Ovarian Neoplasms 456Lung Neoplasms 447Lymphoma, Non-Hodgkin 385Recurrence 374Lymphoma 374Leukemia, Myeloid, Acute 370Pancreatic Neoplasms 358Carcinoma, Renal Cell 339Carcinoma, Hepatocellular 286Stomach Neoplasms 281Leukemia, Lymphocytic, Chronic, B-Cell 268Lymphoma, Follicular 254Head and Neck Neoplasms 246Glioblastoma 220Leukemia 215Small Cell Lung Carcinoma 183Lymphoma, Large B-Cell, Diffuse 183Squamous Cell Carcinoma of Head and Neck 181Urinary Bladder Neoplasms 175Carcinoma 175Uterine Cervical Neoplasms 174Advanced Solid Tumors 161

Interventions

darolutamide 1Rosuvastatin Calcium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Healthy Volunteers × Clear all
NCT06471712 2025-09-08

Clinical Study of 18F-LNC1007 Injection PET/CT

Yantai LNC Biotechnology Singapore PTE. LTD.

Phase 1 Completed
8 enrolled

Healthy Volunteers

NCT06463782 2025-09-03

Clinical Study of 68Ga-LNC1007 Injection PET/CT

Yantai LNC Biotechnology Singapore PTE. LTD.

Phase 1 Completed
8 enrolled

Healthy Volunteers

NCT02671097 2016-09-08

Drug-drug Interaction Study Using Rosuvastatin as a Breast Cancer Resistant Protein (Efflux Transporter), Organic Anion-transporting Polypeptide (OATP)1B1, and OATP1B3 (Uptake Transporters) Probe Substrate

Bayer

Phase 1 Completed
30 enrolled

Healthy Volunteers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡